Cancer cells with reduced PKM2 activity indicated the availability of an alternative pathway where PEP is converted to pyruvate through phosphorylation of PGAM1 by PEP, in which PEP acts as a phosphate donor [52]. The gene discussed is PKM; the disease is cancer.